Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

129 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. Harper JW, et al. Among authors: keyomarsi k. Cell. 1993 Nov 19;75(4):805-16. doi: 10.1016/0092-8674(93)90499-g. Cell. 1993. PMID: 8242751
Inhibition of cyclin-dependent kinases by p21.
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, et al. Harper JW, et al. Among authors: keyomarsi k. Mol Biol Cell. 1995 Apr;6(4):387-400. doi: 10.1091/mbc.6.4.387. Mol Biol Cell. 1995. PMID: 7626805 Free PMC article.
Deregulation of cyclin E in breast cancer.
Keyomarsi K, Conte D Jr, Toyofuku W, Fox MP. Keyomarsi K, et al. Oncogene. 1995 Sep 7;11(5):941-50. Oncogene. 1995. PMID: 7675453
Cyclin E, a redundant cyclin in breast cancer.
Gray-Bablin J, Zalvide J, Fox MP, Knickerbocker CJ, DeCaprio JA, Keyomarsi K. Gray-Bablin J, et al. Among authors: keyomarsi k. Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15215-20. doi: 10.1073/pnas.93.26.15215. Proc Natl Acad Sci U S A. 1996. PMID: 8986790 Free PMC article.
Lovastatin induction of cyclin-dependent kinase inhibitors in human breast cells occurs in a cell cycle-independent fashion.
Gray-Bablin J, Rao S, Keyomarsi K. Gray-Bablin J, et al. Among authors: keyomarsi k. Cancer Res. 1997 Feb 15;57(4):604-9. Cancer Res. 1997. PMID: 9044834
The role of cyclin E in cell proliferation, development and cancer.
Keyomarsi K, Herliczek TW. Keyomarsi K, et al. Prog Cell Cycle Res. 1997;3:171-91. doi: 10.1007/978-1-4615-5371-7_14. Prog Cell Cycle Res. 1997. PMID: 9552414 Review.
Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
Rao S, Lowe M, Herliczek TW, Keyomarsi K. Rao S, et al. Among authors: keyomarsi k. Oncogene. 1998 Nov 5;17(18):2393-402. doi: 10.1038/sj.onc.1202322. Oncogene. 1998. PMID: 9811471
The biphasic induction of p21 and p27 in breast cancer cells by modulators of cAMP is posttranscriptionally regulated and independent of the PKA pathway.
Rao S, Gray-Bablin J, Herliczek TW, Keyomarsi K. Rao S, et al. Among authors: keyomarsi k. Exp Cell Res. 1999 Oct 10;252(1):211-23. doi: 10.1006/excr.1999.4620. Exp Cell Res. 1999. PMID: 10502413
UCN-01-mediated G1 arrest in normal but not tumor breast cells is pRb-dependent and p53-independent.
Chen X, Lowe M, Keyomarsi K. Chen X, et al. Among authors: keyomarsi k. Oncogene. 1999 Oct 7;18(41):5691-702. doi: 10.1038/sj.onc.1202948. Oncogene. 1999. PMID: 10577141
Activation of the estrogen-signaling pathway by p21(WAF1/CIP1) in estrogen receptor-negative breast cancer cells.
Chen X, Danes C, Lowe M, Herliczek TW, Keyomarsi K. Chen X, et al. Among authors: keyomarsi k. J Natl Cancer Inst. 2000 Sep 6;92(17):1403-13. doi: 10.1093/jnci/92.17.1403. J Natl Cancer Inst. 2000. PMID: 10974076
129 results
Jump to page
Feedback